You are here: All Products  > InnoCare Approved to Launch Cytolytic CD-19 Immunotherapy in Hong Kong

InnoCare Approved to Launch Cytolytic CD-19 Immunotherapy in Hong Kong

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products